Rodman & Renshaw Initiates Coverage On Rani Therapeutics Hldgs With Buy Rating, Announces Price Target of $10
Rodman & Renshaw Initiates Coverage On Rani Therapeutics Hldgs With Buy Rating, Announces Price Target of $10
Rodman＆Renshaw對Rani Therapeutics Hldgs進行買入評級，並宣佈目標價格爲$10。
Rodman & Renshaw analyst Brandon Folkes initiates coverage on Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces Price Target of $10.
Rodman＆Renshaw分析師Brandon Folkes開始對Rani Therapeutics Hldgs（納斯達克：RANI）進行買入評級，並宣佈目標價格爲10美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。